DiaMedica Therapeutics (DMAC) Stock Chart & Stock Price History $6.52 -0.09 (-1.42%) As of 02/21/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends DiaMedica Therapeutics Stock Price Performance 5 Day Performance+3.50%1 Month Performance+7.96%3 Month Performance+38.51%6 Month Performance+63.57%Year-To-Date Performance+19.89%1 Year Performance+126.43% Receive DMAC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address DMAC Stock Chart for Saturday, February, 22, 2025 DMAC Chart by TradingView DiaMedica Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025$6.61$6.51-1.51%$6.65$6.4874,665 shs$278.37 million02/20/2025$6.65$6.61-0.60%$6.80$6.5670,764 shs$282.65 million02/19/2025$6.16$6.65+7.95%$6.82$5.75470,749 shs$284.35 million02/18/2025$6.29$6.16-2.07%$6.34$6.0566,713 shs$263.40 million02/17/2025$6.29$6.29$6.37$6.1561,408 shs$268.96 million02/14/2025$6.25$6.29+0.64%$6.37$6.1561,408 shs$268.96 million02/13/2025$6.28$6.25-0.48%$6.30$6.1267,863 shs$267.25 million02/12/2025$6.28$6.28$6.35$6.2370,406 shs$268.53 million02/11/2025$6.38$6.28-1.57%$6.43$6.0526,315 shs$268.53 million02/10/2025$6.26$6.38+1.92%$6.45$6.1681,731 shs$272.81 million Get the Latest News and Ratings for DMAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025$6.19$6.26+1.13%$6.30$6.1054,972 shs$267.68 million02/06/2025$6.03$6.19+2.65%$6.40$5.9990,945 shs$264.68 million02/05/2025$5.98$6.03+0.84%$6.15$6.0080,025 shs$257.84 million02/04/2025$5.90$5.98+1.36%$6.08$5.8656,117 shs$255.71 million02/03/2025$5.76$5.90+2.43%$5.92$5.6146,067 shs$252.29 million01/31/2025$5.85$5.76-1.54%$5.99$5.6053,263 shs$246.30 million01/30/2025$5.89$5.85-0.68%$5.98$5.6729,977 shs$250.15 million01/29/2025$5.95$5.89-1.01%$6.05$5.8523,957 shs$251.86 million01/28/2025$6.06$5.95-1.82%$6.15$5.5271,743 shs$254.42 million01/27/2025$6.30$6.06-3.81%$6.35$6.0357,528 shs$259.13 million01/24/2025$6.25$6.30+0.80%$6.39$6.0480,007 shs$269.39 million01/23/2025$6.03$6.25+3.65%$6.29$5.8587,357 shs$267.25 million01/22/2025$5.80$6.03+3.97%$6.14$5.65108,042 shs$257.84 million01/21/2025$5.71$5.80+1.58%$6.14$5.75120,291 shs$248.01 million Related Companies Enliven Therapeutics Stock Price Chart Phibro Animal Health Stock Price Chart Collegium Pharmaceutical Stock Price Chart Intellia Therapeutics Stock Price Chart Zymeworks Stock Price Chart Cogent Biosciences Stock Price Chart ORIC Pharmaceuticals Stock Price Chart Pharvaris Stock Price Chart Replimune Group Stock Price Chart Rocket Pharmaceuticals Stock Price Chart Receive DMAC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DMAC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaMedica Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DiaMedica Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DMAC Stock Alerts